Micrornas in prostate cancer: an overview

Daniela Vanacore; Mariarosaria Boccellino; Sabrina Rossetti; Carla Cavaliere; Carmine D'Aniello; Rossella Di Franco; Francesco Jacopo Romano; Micaela Montanari; Elvira La Mantia; Raffaele Piscitelli; Flavia Nocerino; Francesca Cappuccio; Giovanni Grimaldi; Alessandro Izzo; Luigi Castaldo; Maria Filomena Pepe; Maria Gabriella Malzone; Gelsomina Iovane; Gianluca Ametrano; Paola Stiuso; Lucio Quagliuolo; Daniela Barberio; Sisto Perdonà; Paolo Muto; Maurizio Montella; Piera Maiolino; Bianca Maria Veneziani; Gerardo Botti; Michele Caraglia; Gaetano Facchini

doi:10.18632/oncotarget.16933

Micrornas in prostate cancer: an overview

Daniela Vanacore, Mariarosaria Boccellino, Sabrina Rossetti, Carla Cavaliere, Carmine D'Aniello, Rossella Di Franco, Francesco Jacopo Romano, Micaela Montanari, Elvira La Mantia, Raffaele Piscitelli, Flavia Nocerino, Francesca Cappuccio, Giovanni Grimaldi, Alessandro Izzo, Luigi Castaldo, Maria Filomena Pepe, Maria Gabriella Malzone, Gelsomina Iovane, Gianluca Ametrano, Paola StiusoLucio Quagliuolo, Daniela Barberio, Sisto Perdonà, Paolo Muto, Maurizio Montella, Piera Maiolino, Bianca Maria Veneziani, Gerardo Botti, Michele Caraglia, Gaetano Facchini

Istituto Nazionale Tumori Fondazione G. Pascale

Research output: Contribution to journal › Review article › peer-review

Abstract

Prostate cancer is the second highest cause of cancer mortality after lung tumours. In USA it affects about 2.8 million men and the incidence increases with age in many countries. Therefore, early diagnosis is a very important step for patient clinical evaluation and for a selective and efficient therapy. The study of miRNAs' functions and molecular mechanisms has brought new knowledge in biological processes of cancer. In prostate cancer there is a deregulation of several miRNAs that may function as tumour suppressors or oncogenes. The aim of this review is to analyze the progress made to our understanding of the role of miRNA dysregulation in prostate cancer tumourigenesis.

Original language	English
Journal	Oncotarget
DOIs	https://doi.org/10.18632/oncotarget.16933
Publication status	Published - Jul 2017

Keywords

Journal Article
Review

Access to Document

10.18632/oncotarget.16933

Cite this

Vanacore, D., Boccellino, M., Rossetti, S., Cavaliere, C., D'Aniello, C., Di Franco, R., Romano, F. J., Montanari, M., La Mantia, E., Piscitelli, R., Nocerino, F., Cappuccio, F., Grimaldi, G., Izzo, A., Castaldo, L., Pepe, M. F., Malzone, M. G., Iovane, G., Ametrano, G., ... Facchini, G. (2017). Micrornas in prostate cancer: an overview. Oncotarget. https://doi.org/10.18632/oncotarget.16933

Vanacore, D, Boccellino, M, Rossetti, S, Cavaliere, C, D'Aniello, C, Di Franco, R, Romano, FJ, Montanari, M, La Mantia, E, Piscitelli, R, Nocerino, F, Cappuccio, F, Grimaldi, G , Izzo, A , Castaldo, L, Pepe, MF, Malzone, MG, Iovane, G, Ametrano, G, Stiuso, P, Quagliuolo, L, Barberio, D , Perdonà, S , Muto, P, Montella, M, Maiolino, P, Veneziani, BM, Botti, G, Caraglia, M & Facchini, G 2017, 'Micrornas in prostate cancer: an overview', Oncotarget. https://doi.org/10.18632/oncotarget.16933

@article{f719d66483854a5396c82e34e4ed0c9c,

title = "Micrornas in prostate cancer: an overview",

abstract = "Prostate cancer is the second highest cause of cancer mortality after lung tumours. In USA it affects about 2.8 million men and the incidence increases with age in many countries. Therefore, early diagnosis is a very important step for patient clinical evaluation and for a selective and efficient therapy. The study of miRNAs' functions and molecular mechanisms has brought new knowledge in biological processes of cancer. In prostate cancer there is a deregulation of several miRNAs that may function as tumour suppressors or oncogenes. The aim of this review is to analyze the progress made to our understanding of the role of miRNA dysregulation in prostate cancer tumourigenesis.",

keywords = "Journal Article, Review",

author = "Daniela Vanacore and Mariarosaria Boccellino and Sabrina Rossetti and Carla Cavaliere and Carmine D'Aniello and {Di Franco}, Rossella and Romano, {Francesco Jacopo} and Micaela Montanari and {La Mantia}, Elvira and Raffaele Piscitelli and Flavia Nocerino and Francesca Cappuccio and Giovanni Grimaldi and Alessandro Izzo and Luigi Castaldo and Pepe, {Maria Filomena} and Malzone, {Maria Gabriella} and Gelsomina Iovane and Gianluca Ametrano and Paola Stiuso and Lucio Quagliuolo and Daniela Barberio and Sisto Perdon{\`a} and Paolo Muto and Maurizio Montella and Piera Maiolino and Veneziani, {Bianca Maria} and Gerardo Botti and Michele Caraglia and Gaetano Facchini",

year = "2017",

month = jul,

doi = "10.18632/oncotarget.16933",

language = "English",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

}

TY - JOUR

T1 - Micrornas in prostate cancer

T2 - an overview

AU - Vanacore, Daniela

AU - Boccellino, Mariarosaria

AU - Rossetti, Sabrina

AU - Cavaliere, Carla

AU - D'Aniello, Carmine

AU - Di Franco, Rossella

AU - Romano, Francesco Jacopo

AU - Montanari, Micaela

AU - La Mantia, Elvira

AU - Piscitelli, Raffaele

AU - Nocerino, Flavia

AU - Cappuccio, Francesca

AU - Grimaldi, Giovanni

AU - Izzo, Alessandro

AU - Castaldo, Luigi

AU - Pepe, Maria Filomena

AU - Malzone, Maria Gabriella

AU - Iovane, Gelsomina

AU - Ametrano, Gianluca

AU - Stiuso, Paola

AU - Quagliuolo, Lucio

AU - Barberio, Daniela

AU - Perdonà, Sisto

AU - Muto, Paolo

AU - Montella, Maurizio

AU - Maiolino, Piera

AU - Veneziani, Bianca Maria

AU - Botti, Gerardo

AU - Caraglia, Michele

AU - Facchini, Gaetano

PY - 2017/7

Y1 - 2017/7

N2 - Prostate cancer is the second highest cause of cancer mortality after lung tumours. In USA it affects about 2.8 million men and the incidence increases with age in many countries. Therefore, early diagnosis is a very important step for patient clinical evaluation and for a selective and efficient therapy. The study of miRNAs' functions and molecular mechanisms has brought new knowledge in biological processes of cancer. In prostate cancer there is a deregulation of several miRNAs that may function as tumour suppressors or oncogenes. The aim of this review is to analyze the progress made to our understanding of the role of miRNA dysregulation in prostate cancer tumourigenesis.

AB - Prostate cancer is the second highest cause of cancer mortality after lung tumours. In USA it affects about 2.8 million men and the incidence increases with age in many countries. Therefore, early diagnosis is a very important step for patient clinical evaluation and for a selective and efficient therapy. The study of miRNAs' functions and molecular mechanisms has brought new knowledge in biological processes of cancer. In prostate cancer there is a deregulation of several miRNAs that may function as tumour suppressors or oncogenes. The aim of this review is to analyze the progress made to our understanding of the role of miRNA dysregulation in prostate cancer tumourigenesis.

KW - Journal Article

KW - Review

U2 - 10.18632/oncotarget.16933

DO - 10.18632/oncotarget.16933

M3 - Review article

C2 - 28445135

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

ER -

Micrornas in prostate cancer: an overview

Abstract

Keywords

Access to Document

Fingerprint

Cite this